ArticleBreast cancer research and treatment2019

4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.

Gen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.